|
1
|
DeSantis CE, Ma J, Goding Sauer A, Newman
LA and Jemal A: Breast cancer statistics, 2017, racial disparity in
mortality by state. CA Cancer J Clin. 67:439–448. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ngamcherdtrakul W, Castro DJ, Gu S, Morry
J, Reda M, Gray JW and Yantasee W: Current development of targeted
oligonucleotide-based cancer therapies: Perspective on
HER2-positive breast cancer treatment. Cancer Treat Rev. 45:19–29.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maruti SS, Willett WC, Feskanich D, Rosner
B and Colditz GA: A prospective study of age-specific physical
activity and premenopausal breast cancer. J Natl Cancer Inst.
100:728–737. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hiatt RA, Klabunde C, Breen N, Swan J and
Ballard-Barbash R: Cancer screening practices from National Health
Interview Surveys: Past, present, and future. J Natl Cancer Inst.
94:1837–1846. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Slatkin M: Linkage
disequilibrium-understanding the evolutionary past and mapping the
medical future. Nat Rev Genet. 9:477–485. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim IA, No M, Lee JM, Shin JH, Oh JS, Choi
EJ, Kim IH, Atadja P and Bernhard EJ: epigenetic modulation of
radiation response in human cancer cells with activated EGFR or
HER-2 signaling: Potential role of histone deacetylase 6. Radiother
Oncol. 92:125–132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lakhani SR, Van De Vijver MJ, Jacquemier
J, Anderson TJ, Osin PP, McGuffog L and Easton DF: The pathology of
familial breast cancer: Predictive value of immunohistochemical
markers estrogen receptor, progesterone receptor, HER-2, and p53 in
patients with mutations in BRCA1 and BRCA2. J Clin
Oncol. 20:2310–2318. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kyndi M, Sørensen FB, Knudsen H, Overgaard
M, Nielsen HM and Overgaard J; Danish Breast Cancer Cooperative
Group, : Estrogen receptor, progesterone receptor, HER-2, and
response to postmastectomy radiotherapy in high-risk breast cancer:
The Danish Breast Cancer Cooperative Group. J Clin Oncol.
26:1419–1426. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jeng RL, Goley ED, D'Alessio JA, Chaga OY,
Svitkina TM, Borisy GG, Heinzen RA and Welch MD: A
Rickettsia WASP-like protein activates the Arp2/3 complex
and mediates actin-based motility. Cell Microbiol. 6:761–769. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Goley ED and Welch MD: The ARP2/3 complex:
An actin nucleator comes of age. Nat Rev Mol Cell Biol. 7:713–726.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Frank DJ, Hopmann R, Lenartowska M and
Miller KG: Capping protein and the Arp2/3 complex regulate
nonbundle actin filament assembly to indirectly control actin
bundle positioning during Drosophila melanogaster bristle
development. Mol Biol Cell. 17:3930–3939. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Al Ghouleh I, Rodríguez A, Pagano PJ and
Csányi G: Proteomic analysis identifies an NADPH oxidase 1
(Nox1)-mediated role for actin-related protein 2/3 complex subunit
2 (ARPC2) in promoting smooth muscle cell migration. Int J Mol Sci.
14:20220–20235. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang J, Liu Y, Yu CJ, Dai F, Xiong J, Li
HJ, Wu ZS, Ding R and Wang H: Role of ARPC2 in human gastric
cancer. Mediators Inflamm. 2017:54328182017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Moreno-Bueno G, Portillo F and Cano A:
Transcriptional regulation of cell polarity in EMT and cancer.
Oncogene. 27:6958–6969. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wright JA, Richer JK and Goodall GJ:
microRNAs and EMT in mammary cells and breast cancer. J Mammary
Gland Biol Neoplasia. 15:213–223. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Creighton CJ, Chang JC and Rosen JM:
Epithelial-mesenchymal transition (EMT) in tumor-initiating cells
and its clinical implications in breast cancer. J Mammary Gland
Biol Neoplasia. 15:253–260. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hardy KM, Booth BW, Hendrix MJ, Salomon DS
and Strizzi L: ErbB/EGF signaling and EMT in mammary development
and breast cancer. J Mammary Gland Biol Neoplasia. 15:191–199.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Doble BW and Woodgett JR: Role of glycogen
synthase kinase-3 in cell fate and epithelial-mesenchymal
transitions. Cells Tissues Organs. 185:73–84. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu J, Lamouille S and Derynck R:
TGF-beta-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kudo-Saito C, Shirako H, Takeuchi T and
Kawakami Y: Cancer metastasis is accelerated through
immunosuppression during snail-induced EMT of cancer cells. Cancer
Cell. 15:195–206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gavert N and Ben-Ze'ev A:
Epithelial-mesenchymal transition and the invasive potential of
tumors. Trends Mol Med. 14:199–209. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma XJ, Dahiya S, Richardson E, Erlander M
and Sgroi DC: Gene expression profiling of the tumor
microenvironment during breast cancer progression. Breast Cancer
Res. 11:R72009. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Curtis C, Shah SP, Chin SF, Turashvili G,
Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, et
al: The genomic and transcriptomic architecture of 2,000 breast
tumours reveals novel subgroups. Nature. 486:346–352. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao H, Langerod A, Ji Y, Nowels KW,
Nesland JM, Tibshirani R, Bukholm IK, Kåresen R, Botstein D,
Børresen-Dale AL, et al: Different gene expression patterns in
invasive lobular and ductal carcinomas of the breast. Mol Biol
Cell. 15:2523–2536. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Abella JV, Galloni C, Pernier J, Barry DJ,
Kjær S, Carlier MF and Way M: Isoform diversity in the Arp2/3
complex determines actin filament dynamics. Nat Cell Biol.
18:76–86. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Robinson R, Turbedsky K, Kaiser D,
Marchand J, Higgs H, Choe S and Pollard T: Crystal structure of
Arp2/3 complex. Science. 294:1679–1684. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Daugherty KM and Goode BL: Functional
surfaces on the p35/ARPC2 subunit of Arp2/3 complex required for
cell growth, actin nucleation, and endocytosis. J Biol Chem.
283:16950–16959. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Saedler R, Mathur N, Srinivas BP,
Kernebeck B, Hülskamp M and Mathur J: Actin control over
microtubules suggested by DISTORTED2 encoding the
Arabidopsis ARPC2 subunit homolog. Plant Cell Physiol.
45:813–822. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Franke A, Balschun T, Karlsen TH,
Sventoraityte J, Nikolaus S, Mayr G, Domingues FS, Albrecht M,
Nothnagel M, Ellinghaus D, et al: Sequence variants in IL10,
ARPC2 and multiple other loci contribute to ulcerative colitis
susceptibility. Nat Genet. 40:1319–1323. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shapiro IM, Cheng AW, Flytzanis NC,
Balsamo M, Condeelis JS, Oktay MH, Burge CB and Gertler FB: An
EMT-driven alternative splicing program occurs in human breast
cancer and modulates cellular phenotype. PLoS Genet.
7:e10022182011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cannito S, Novo E, di Bonzo LV, Busletta
C, Colombatto S and Parola M: Epithelial-mesenchymal transition:
From molecular mechanisms, redox regulation to implications in
human health and disease. Antioxid Redox Signal. 12:1383–1430.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mendez MG, Kojima S and Goldman RD:
Vimentin induces changes in cell shape, motility, and adhesion
during the epithelial to mesenchymal transition. FASEB J.
24:1838–1851. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Prasain N and Stevens T: The actin
cytoskeleton in endothelial cell phenotypes. Microvasc Res.
77:53–63. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hur W, Rhim H, Jung CK, Kim JD, Bae SH,
Jang JW, Yang JM, Oh ST, Kim DG, Wang HJ, et al: SOX4
overexpression regulates the p53-mediated apoptosis in
hepatocellular carcinoma: Clinical implication and functional
analysis in vitro. Carcinogenesis. 31:1298–1307. 2010. View Article : Google Scholar : PubMed/NCBI
|
